Professor Graham Jackson, Royal Victoria Infirmary, Newcastle-Upon-Tyne, UK.
UNSW Australia researchers have shown that changing just a single letter of the DNA of human red blood cells in the laboratory increases their production of oxygen-carrying haemoglobin… read more.
by Bruce Sylvester: Researchers from a phase 3, randomized trial of brentuximab vedotin report that adults with hard-to-treat Hodgkin lymphoma treated with brentuximab vedotin immediately after stem cell… read more.
by Bruce Sylvester: A blood test administered between weeks 10 and 14 weeks of pregnancy appears to be a more accurate diagnostic tool for Down syndrome and two… read more.
The first blood test for osteoarthritis could soon be developed, thanks to research by the University of Warwick. The research findings could potentially lead to patients being tested… read more.
Professor Stephen Ansell, Mayo Clinic, Rochester, MN, USA. Dr Robert Chen, City of Hope, Duarte, CA, USA. Professor Ajay Gopal, University of Washington, WA, USA.
by Thomas R. Collins: Treating patients with T-cell lymphomas is fraught with challenges, requiring new approaches and sharper diagnosis, said Timothy Illidge, MD, PhD, Professor of Targeted Therapy… read more.
by Thomas R. Collins: The use of chimeric antigen receptor T-cells — in which a patient’s own T cells are modified to fight cancer cells — is showing good results… read more.
by Thomas R. Collins: Pursuit of useful risk biomarkers in HL still a work-in-progress. The quest for biomarkers in classic Hodgkin lymphoma, to determine which patients are at a… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
